Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease.
Emilie E van LingenSimon Mark Dahl JørgensenSimone S C LieberknechtNicolas N BenechGianluca G IaniroHarry H SokolAlessandro A GasbarriniGiovanni G CammarotaMarcel M K EriksenAndrea A E van der Meulen-de JongElizabeth E M TerveerHein H W VerspagetMaria M VehreschildChristian C L HvasJosbert J J KellerPublished in: Therapeutic advances in gastroenterology (2023)
FMT for rCDI in IBD patients is safe and effective, and IBD exacerbation after FMT is infrequent. Further studies should investigate the effects on IBD course following FMT.
Keyphrases
- patients with inflammatory bowel disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic obstructive pulmonary disease
- chronic kidney disease
- clostridium difficile
- prognostic factors
- peritoneal dialysis
- stem cells
- mesenchymal stem cells
- combination therapy
- acute respiratory distress syndrome
- smoking cessation